1. Pink Sheet
  2. >>Compliance

The Economics Of Drug Shortages: US FDA Seeks Broad Input

 
• By Cole Werble

FDA is planning series of stakeholder meetings to identify new approaches to drug shortages, with particular interest in defining “essential” drugs. Agency is also looking outside for expertise, with Boston University’s Rena Conti tapped as advisor.

Fisherman casting his net at the sunset at Mae Klong River, Thailand
US FDA is casting a wide net to find potential shortage solutions

The definition of “essential” or “critical” drugs in terms of shortages will be one of the US FDA’s key interests during the series of listening sessions with stakeholders being held during September and October, and at a broader open public meeting set for Nov. 27.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Manufacturing

More from Compliance